Market Cap 11.80M
Revenue (ttm) 3.22M
Net Income (ttm) -4.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -141.30%
Debt to Equity Ratio 0.00
Volume 79,900
Avg Vol 290,682
Day's Range N/A - N/A
Shares Out 6.71M
Stochastic %K 32%
Beta 0.71
Analysts Sell
Price Target $5.00

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3 Carlton South, Carlton, Australia
Baseball89
Baseball89 Aug. 19 at 8:05 PM
$HCTI $IMRN --keep watch. Ready for a run. $BTAI ---need catalyst
0 · Reply
Rum3002576
Rum3002576 Aug. 19 at 1:08 PM
0 · Reply
Baseball89
Baseball89 Aug. 19 at 12:42 PM
$BTAI $IMRN https://finance.yahoo.com/news/immuron-letter-shareholders-projects-100000440.html
0 · Reply
Timtheshark
Timtheshark Aug. 18 at 7:59 PM
0 · Reply
JL_TradeZ
JL_TradeZ Aug. 18 at 6:32 PM
$IMRN Textbook move, played out exactly like we planned as our Special Play 🔥🔥
0 · Reply
ALDX_Bull
ALDX_Bull Aug. 18 at 6:29 PM
$IMRN data is likely unblinded and stock is performing well. Most important study in company history.
0 · Reply
Baseball89
Baseball89 Aug. 14 at 5:38 PM
$BTAI $IMRN ---looks like it's breaking out
1 · Reply
Baseball89
Baseball89 Aug. 14 at 5:36 PM
$BMNR $IMRN ----solid starting to run what's going on it's breaking out $HCTI --let:s go
0 · Reply
Baseball89
Baseball89 Aug. 14 at 4:26 PM
$BTAI $IMRN unusual activity. Looks ready for a breakout.
0 · Reply
Baseball89
Baseball89 Aug. 14 at 10:14 AM
$BMNR $IMRN ---strong fundamentals,6k filing and emerging conference,earning this month.
0 · Reply
Latest News on IMRN
Immuron Letter to Shareholders: Projects Update

May 30, 2025, 6:00 AM EDT - 2 months ago

Immuron Letter to Shareholders: Projects Update


Immuron Travelan® highest sales in history

Apr 10, 2025, 6:00 PM EDT - 4 months ago

Immuron Travelan® highest sales in history


Immuron Travelan® continued strong sales growth

Jan 17, 2025, 6:00 AM EST - 7 months ago

Immuron Travelan® continued strong sales growth


Immuron Announces Travelan® Clinical Trial Update

Jan 14, 2025, 6:00 AM EST - 7 months ago

Immuron Announces Travelan® Clinical Trial Update


Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Sep 5, 2024, 11:54 AM EDT - 1 year ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review


Immuron requests pre-IND meeting for IMM-529 with FDA filing

Jul 2, 2024, 6:00 AM EDT - 1 year ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing


Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron Board Changes


Immuron CEO Steven Lydeamore to present at Peak Sky High

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore to present at Peak Sky High


Immuron Limited to Present at the Emerging Growth Conference

May 7, 2024, 6:00 AM EDT - 1 year ago

Immuron Limited to Present at the Emerging Growth Conference


Immuron Director Resignation

May 3, 2024, 6:00 AM EDT - 1 year ago

Immuron Director Resignation


Immuron to host Live Virtual Event

Apr 15, 2024, 6:00 AM EDT - 1 year ago

Immuron to host Live Virtual Event


Immuron Travelan® sales continued strong growth

Apr 10, 2024, 6:00 AM EDT - 1 year ago

Immuron Travelan® sales continued strong growth


Immuron Presentation Australian Biologics Festival 2024

Feb 21, 2024, 6:00 AM EST - 1 year ago

Immuron Presentation Australian Biologics Festival 2024


Immuron achieves record Travelan® sales

Feb 13, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record Travelan® sales


Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Feb 8, 2024, 6:00 AM EST - 1 year ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation


Immuron achieves record half yearly Travelan® sales

Jan 16, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record half yearly Travelan® sales


Immuron Clinical Trials Update

Dec 22, 2023, 6:00 AM EST - 1 year ago

Immuron Clinical Trials Update


Immuron CEO Steven Lydeamore Investor Webinar Presentation

Nov 13, 2023, 6:00 PM EST - 1 year ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation


Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 30, 2023, 7:21 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore presented at AusBioInvest


Immuron Announces Travelan® Clinical Study Cohort 2 commences

Oct 18, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces Travelan® Clinical Study Cohort 2 commences


Immuron achieves record quarterly Travelan® sales

Oct 11, 2023, 6:00 AM EDT - 2 years ago

Immuron achieves record quarterly Travelan® sales


Immuron achieves record monthly Travelan® sales

Sep 13, 2023, 6:00 AM EDT - 2 years ago

Immuron achieves record monthly Travelan® sales


Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Sep 11, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright


Immuron CEO, Steven Lydeamore to present at Bioshares

Jul 24, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Bioshares


Immuron FY23 Sales increase 136% on FY22 Sales

Jul 5, 2023, 6:00 AM EDT - 2 years ago

Immuron FY23 Sales increase 136% on FY22 Sales


Immuron Chairman Transition

Jun 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Chairman Transition


Immuron Business Update: Letter to Shareholders

Jun 22, 2023, 6:00 AM EDT - 2 years ago

Immuron Business Update: Letter to Shareholders


Immuron Initiates Recruitment of Travelan® Clinical Study

May 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Initiates Recruitment of Travelan® Clinical Study


Baseball89
Baseball89 Aug. 19 at 8:05 PM
$HCTI $IMRN --keep watch. Ready for a run. $BTAI ---need catalyst
0 · Reply
Rum3002576
Rum3002576 Aug. 19 at 1:08 PM
0 · Reply
Baseball89
Baseball89 Aug. 19 at 12:42 PM
$BTAI $IMRN https://finance.yahoo.com/news/immuron-letter-shareholders-projects-100000440.html
0 · Reply
Timtheshark
Timtheshark Aug. 18 at 7:59 PM
0 · Reply
JL_TradeZ
JL_TradeZ Aug. 18 at 6:32 PM
$IMRN Textbook move, played out exactly like we planned as our Special Play 🔥🔥
0 · Reply
ALDX_Bull
ALDX_Bull Aug. 18 at 6:29 PM
$IMRN data is likely unblinded and stock is performing well. Most important study in company history.
0 · Reply
Baseball89
Baseball89 Aug. 14 at 5:38 PM
$BTAI $IMRN ---looks like it's breaking out
1 · Reply
Baseball89
Baseball89 Aug. 14 at 5:36 PM
$BMNR $IMRN ----solid starting to run what's going on it's breaking out $HCTI --let:s go
0 · Reply
Baseball89
Baseball89 Aug. 14 at 4:26 PM
$BTAI $IMRN unusual activity. Looks ready for a breakout.
0 · Reply
Baseball89
Baseball89 Aug. 14 at 10:14 AM
$BMNR $IMRN ---strong fundamentals,6k filing and emerging conference,earning this month.
0 · Reply
Baseball89
Baseball89 Aug. 14 at 9:56 AM
$IMRN 6k filing, emerging growth conference and earnings this month. Overnight activity.
0 · Reply
ALDX_Bull
ALDX_Bull Aug. 14 at 7:47 AM
$IMRN every day closer to results from groundbreaking study. If it works well, then many millions more in sales near term and a clear path to fda approval.
0 · Reply
mmqwerty00
mmqwerty00 Aug. 4 at 4:04 PM
$IMRN While I think there is real value here, the problem at the end of the day is that this is a microcap sub 10M MC in Australia, with its revenue coming but its growth in US market being driven based on what it can sell on Amazon. Thats reality. No market makers/institutions are going to touch this/care. Steve needs to be out there more - doing coffee microcaps once every couple months isn't going to cut it. They need a real IR to generate interest, otherwise, getting retail to care at the volumes needed to get this moving will be difficult unless its "news" days where volume sky rockets...before careening down again. Steve is doing great on sales, but needs to manage the stock much better - some real IR may be needed at some point
1 · Reply
Baseball89
Baseball89 Aug. 3 at 1:41 PM
$IMRN market makers need to place some attention on this ticker. It's solid and has potential to go to $20
1 · Reply
ALDX_Bull
ALDX_Bull Aug. 1 at 4:58 PM
$IMRN Uniformed Services study topline data is all that matters here. Works well and DoD itself will order millions in product.
0 · Reply
mmqwerty00
mmqwerty00 Aug. 1 at 3:56 PM
$IMRN Frankly the recent presentation was a bit of a disappointment. They need to show a slowing cash burn in their next earnings release - should be by end of August and they need to be the Uniformed Services study topline data out ASAP Forget IM529 and IMM986 - those are way, way off in terms of getting support on stock price
1 · Reply
mmqwerty00
mmqwerty00 Aug. 1 at 3:54 PM
0 · Reply
dkstew
dkstew Aug. 1 at 2:00 PM
$IMRN guess we can expect to continue the very slow grind down until some news. Price was about a $1 more a year ago.
1 · Reply
mmqwerty00
mmqwerty00 Aug. 1 at 1:44 AM
$IMRN Gobble up anything under $2 - look at the last 6K - the shares they just sold in AUD were @ an equivalent of $2.12/ADS in USD. These guys have a product that is profitable and some irons in the fire. One day this will pop to $4-$5 out of nowhere - gobble up the shares...sit back...and wait...may be awhile but this will definitely double from these levels. Not cash flow positive yet but this is not a pie in the sky bio - while they have that potential, they already have a profitable product. This is not the old team that lead that disaster a couple years back...Steve has this thing moving
1 · Reply
Baseball89
Baseball89 Jul. 31 at 1:11 PM
$PBM $IMRN ---strong earnings,no RS. Unusual activity.
0 · Reply
Li9999
Li9999 Jul. 30 at 12:20 AM
$IMRN AH very good sign for tomorrow
0 · Reply
Baseball89
Baseball89 Jul. 29 at 2:16 PM
$CLSD $ABP is climbing. $IMRN solid
0 · Reply